AmeriFlex Group’s AbbVie ABBV Stock Holding History

AmeriFlex Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$967K	Buy	3,842 +27	+0.7%	+$5.81K	0.4%	54
2026 Q1	$830K	Sell	3,815 -181	-5%	-$40.1K	0.42%	50
2025 Q4	$913K	Sell	3,996 -38	-0.9%	-$8.66K	0.47%	38
2025 Q3	$934K	Sell	4,034 -2,019	-33%	-$411K	0.35%	52
2025 Q2	$1.13M	Sell	6,053 -251	-4%	-$46.6K	0.59%	39
2025 Q1	$1.32M	Buy	6,304 +3,248	+106%	+$631K	0.54%	43
2024 Q4	$562K	Buy	+3,056	New	+$562K	0.26%	85

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AmeriFlex Group's ABBV Position: Q2 2026 in Review

AmeriFlex Group increased its AbbVie (ABBV) stake by 0.71% in Q2 2026, buying an estimated $5.81K and bringing the position to 3,842 shares worth $967K. The position accounts for 0.4% of the portfolio, ranked #54.

AmeriFlex Group first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.32M in Q1 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

AmeriFlex Group held 3,842 shares of AbbVie worth $967K as of Q2 2026.
AmeriFlex Group bought 27 AbbVie shares in Q2 2026, an estimated $5.81K.
AbbVie made up 0.4% of AmeriFlex Group's portfolio in Q2 2026, its #54 holding.
AmeriFlex Group first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
AmeriFlex Group's AbbVie position peaked at $1.32M in Q1 2025.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.